
Overview
Dr. Chanu Rhee is an infectious disease and critical care physician, Medical Director of Infection Control at Brigham and Women’s Hospital, and Associate Professor of Medicine at Harvard Medical School. He graduated summa cum laude from Georgetown University School of Medicine and completed his internal medicine residency, chief residency, and critical care medicine fellowship at Stanford University Hospital followed by an infectious disease fellowship in the combined Massachusetts General Hospital / Brigham and Women’s Hospital program and an MPH degree from the Harvard T.H. Chan School of Public Health. Dr. Rhee is internationally recognized for his expertise and contributions to the epidemiology, surveillance, diagnosis, and treatment of sepsis, particularly through the innovative use of electronic health record data to generate insights that inform clinical practice, quality improvement, and public health policy. His areas of focus also include infection prevention and control, antimicrobial resistance and stewardship, infections in immunocompromised patients, and the care of critically ill patients. He has been a leader in sepsis quality improvement efforts within the Mass General Brigham healthcare system and has participated in many national committees focused on enhancing sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel.Dr. Rhee attends clinically on the transplant / oncology infectious disease service and the Medical ICU at Brigham and Women’s Hospital. In his role as Medical Director of Infection Control, he leads institutional efforts to prevent healthcare-associated infections, investigate outbreaks, and advance patient safety. He is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine. He has served as principal or lead investigator on multiple federally funded grants, has authored over 200 peer-reviewed articles, and is recognized by ScholarGPS as one of the world’s most highly cited and influential experts on sepsis.
Dr. Rhee is rated as an Elite provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Severe Acute Respiratory Syndrome (SARS), Hospital-Acquired Pneumonia, and Pneumonia.
His clinical research consists of co-authoring 210 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 116 articles in the study of Sepsis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
75 Francis St, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Brigham And Womens Physicians Organization Inc
Michael Klompas is an Infectious Disease provider in Boston, Massachusetts. Dr. Klompas is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Hospital-Acquired Pneumonia, Pneumonia, Sepsis, and Severe Acute Respiratory Syndrome (SARS). Dr. Klompas is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Dr. Li is an infectious disease physician-scientist at the Brigham and Women’s Hospital and Harvard Medical School. He leads an active clinical and translational laboratory research program focused on viral detection, reservoirs and resistance, especially within the fields of HIV and COVID-19.Dr. Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the AIDS Clinical Trials Group (ACTG) Executive Committee. He is the protocol co-Chair of the ACTG A5308 study of ART treatment for HIV-1 controllers, the co-Chair of the A5345 study of biomarkers of HIV rebound, and the protocol virologist for A5401/ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19. Dr. Li also serves as the Deputy Editor for the Infectious Disease Society of America (IDSA) journal Open Forum Infectious Diseases and on the Editorial Advisory Board for the Journal of Infectious Diseases. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, COVID-19, Sepsis, Prostatectomy, and Nephrectomy.
Bruce Walker is an Infectious Disease provider in Cambridge, Massachusetts. Dr. Walker is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Sepsis, COVID-19, and Severe Acute Respiratory Syndrome (SARS).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- SepsisDr. Rhee isElite. Learn about Sepsis.
- Advanced
- COVID-19Dr. Rhee isAdvanced. Learn about COVID-19.
- Hospital-Acquired PneumoniaDr. Rhee isAdvanced. Learn about Hospital-Acquired Pneumonia.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- PneumoniaDr. Rhee isAdvanced. Learn about Pneumonia.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- FluDr. Rhee isExperienced. Learn about Flu.
- MediastinitisDr. Rhee isExperienced. Learn about Mediastinitis.
- Necrotizing FasciitisDr. Rhee isExperienced. Learn about Necrotizing Fasciitis.
- ParainfluenzaDr. Rhee isExperienced. Learn about Parainfluenza.


